2(5H)-Furanone, 5-hydroxy-4-methyl- → ethyl [4-methyl-6-oxopyridazin-1(6H)-yl]acetate
反応式
O[CH:2]1O[C:5](=[O:7])[CH:4]=[C:3]1[CH3:8].Cl.[NH:10]([CH2:12][C:13]([O:15][CH2:16][CH3:17])=[O:14])[NH2:11]>C(O)C>[CH2:16]([O:15][C:13](=[O:14])[CH2:12][N:10]1[C:5](=[O:7])[CH:4]=[C:3]([CH3:8])[CH:2]=[N:11]1)[CH3:17]参加物
4
実験手順
5-Hydroxy-4-methylfuran-2(5H)-one (1.19 g, 10.4 mmol) and ethyl hydrazinoacetate hydrochloride (1.61 g, 10.4 mmol) in 95% ethanol (20 mL) was refluxed for 2 h. Removal of the solvent in vacuo followed by purification using a Biotage Horizon® system (0-50% ethyl acetate/hexanes mixture) gave ethyl[4-methyl-6-oxopyridazin-1(6H)-yl]acetate as a yellow crystalline. LC/MS 219.2 (M+23).
後処理
- customRemoval of the solvent in vacuo
- customfollowed by purification
出典と根拠
- ORDレコード
- ord-8e4e4931067848af9008f593bf1ade5b
- 出典データセット
- uspto-grants-2012_08
- 特許番号
- US08247415B2
反応ノート
読み込み中…